Cargando…
Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells
PURPOSE: To determine the ocular anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist (SEGRA) in primary human conjunctival fibroblasts and epithelial cells. METHODS: Two primary human conjunctival cell types, human conjunctival epithelial cells (HConEpiC) and human...
Autores principales: | Cavet, Megan E., Volhejn, Stepan, Harrington, Karen L., Zhang, Jin-Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716413/ https://www.ncbi.nlm.nih.gov/pubmed/23878502 |
Ejemplares similares
-
Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells
por: Cavet, Megan E., et al.
Publicado: (2010) -
Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist
por: Baiula, Monica, et al.
Publicado: (2011) -
Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy
por: Baiula, Monica, et al.
Publicado: (2014) -
BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells
por: Zhang, Jin-Zhong, et al.
Publicado: (2009) -
Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells
por: Cavet, Megan E., et al.
Publicado: (2011)